Beyond the Fixed Dose in Theranostics: Pragmatic Dosimetry as the Missing Link in Optimizing Precision Nuclear Oncology
Akram Al-Ibraheem, Kalevi Kairemo · 2026
Read Beyond the Fixed Dose in Theranostics: Pragmatic Dosimetry as the Missing Link in Optimizing Precision Nuclear Oncology by Akram Al-Ibraheem, Kalevi Kairemo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13612128.txt.
Description
Akram Al-Ibraheem and Kalevi Kairemo argue for patient level dose checks in nuclear cancer care, in a viewpoint from 2026. Targeted radiation drugs have won real gains in precision oncology care. Yet most approved drugs still use fixed or weight based amounts from group trials.
Same given amount can yield very different tumour and organ doses per patient. Tumour load, target levels, organ size, and kidney function all shift that dose. Paired imaging can pick who should be treated for best effect. Dose maths then sets how much that person should receive for balance. The authors call practical dosimetry the missing link for true precision care.
Catalog record
| CREATOR | Akram Al-Ibraheem, Kalevi Kairemo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |